Three pioneering projects across the East will share in £200,000 to help develop technological solutions to currently unmet healthcare needs.
The Medtech Accelerator, a new company set up to provide funding for medical technology and software innovations originating primarily from within the NHS, today announced the first round of successful projects.
Following the first call for applications to the Medtech Accelerator, awards go to:
Arterial GlucoSave – Dr Maryanne Mariyaselvam and Dr Peter Young – Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust
A patient safety solution to eliminate the common error of incorrect fluids being administered as the flush solution prior to blood sampling from an arterial line in the critical care setting. A sodium chloride solution is the recommended flush solution but can often be confused with glucose-containing bags. This can result in artefactually high glucose concentrations in blood samples drawn from the arterial line leading to insulin administration causing hypoglycaemia and fatal neuroglycopenic brain injury. The Arterial GlucoSave technology designs out this error and the award will be used to take early prototypes through to a CE marked medical device ready for market.
Bacteriophage-based solution for the treatment of implant related infections – Professor Iain McNamara – Norfolk and Norwich University Hospitals NHS Foundations Trust
Bacterial infection accounts for 25% of revision hip and knee replacement operations resulting in surgical site infections (SSIs) in orthopaedic surgery. Revision of infected implants is associated with substantial morbidity and economic cost. This project will develop a new biologic based product coating (bacteriophage) for implanted prosthetic materials to eradicate bacterial infections in revision hip and knee joint replacement surgery. The award brings together four parties and will cover both the initial production and testing of the bacteriophage in an in-house model system with a view to designing a path for commercialisation.
Helping children with ‘glue ear’ to hear – Dr Tamsin Brown – Cambridgeshire Community Services NHS Trust
The development of a novel bone conduction headset technology for children with long-term glue ear, the persistent build-up of ear wax in the ear canal. The technology will be used in the school, clinical and home settings to overcome the child’s hearing loss, preventing them from falling behind at school at a crucial development stage. The award will allow the team to further build up the business case for the technology including gaining market insight to progress product development.
The Medtech Accelerator was launched at the end of 2016 as a unique joint venture between the NHS and regional business partners including Health Enterprise East (HEE), New Anglia Local Enterprise Partnership, Greater Cambridge Greater Peterborough (GCGP) Local Enterprise Partnership, and the Eastern Academic Health Science Network (AHSN). The company recognises the current lack of funding available for proof of concept work in healthcare, and provides necessary support and financing for NHS-led projects in order to maximise the potential for success in bringing new life enhancing technologies to patients.
A total of £1.5 million is available with individual awards to be made of between £15,000 and £125,000 to innovation projects that show the potential to create future spin-out companies primarily out of NHS organisations. Awards are aimed at supporting proof of concept work which might include IP protection, market analysis, prototype development and testing, clinical evaluation, regulatory support and pilot product production.